Ruijin Hospital

This early-phase study tests a new drug, cizutamig, in 15 adults with moderate to severe ulcerative colitis who have not responded to other treatments. The main goal is to check if the drug is safe and tolerable. Researchers will monitor side effects and how the body reacts to th…

This study looks at a new vaccine called KSD-101 for people with blood cancers linked to the Epstein-Barr virus (EBV). The vaccine is designed to train the body's immune system to attack cancer cells. Researchers will track how many patients' tumors shrink or disappear, and monit…

This early-stage study tests whether combining three drugs (sonrotoclax, zanubrutinib, and obinutuzumab) can shrink or eliminate mantle cell lymphoma in people with aggressive forms of the disease. About 28 newly diagnosed patients with high-risk features will receive the combina…

This study aims to create a computer model that can predict delirium—a sudden confused state—in hospital ICU patients. Researchers will use cameras to capture tiny facial expressions and combine that data with other health information. The goal is to catch delirium earlier and mo…